EX-10.14S-1/A·CIK 1838003·0001104659-26-128582

Subscription Agreement

View original filing on SEC EDGAR → ·  seen Nov 16, 2026, 17:26 EST

E****xhibit 10.14

** **

ENCORE MEDICAL, INC.
SUBSCRIPTION Agreement

Encore Medical, Inc., a Minnesota corporation (the “Company”), is offering (the “Offering”), on a best-efforts, minimum/maximum basis, a minimum of 800,000 shares of its common stock (the “Minimum”) and a maximum of 1,400,000 shares of its common stock (the “Maximum”), at a public offering price of $5.00 per share (the “Shares”), for minimum gross proceeds of $4,000,000 and maximum gross proceeds of $7,000,000, pursuant to the Company's registration statement on Form S-1 (File No. 333-290244), as declared effective by the Securities and Exchange Commission, and the final prospectus forming a part thereof, as supplemented or amended (the “Prospectus”).

The Offering is being conducted through the placement agents identified in the Prospectus (the “Placement Agents”) pursuant to a Placement Agency Agreement entered into by the Company and the Placement Agents. The Placement Agents are not obligated to purchase any Shares or to sell any specific number of Shares in the Offering.

SUBSCRIPTION AMOUNT.

Number of shares purchased: __________________________________

Aggregate purchase price: ____________________________________

The undersigned hereby subscribes to purchase the number of Shares specified above at a purchase price of $5.00 per Share, subject to acceptance by the Company and the terms and conditions of the Offering described in the Placement Agency Agreement and the Prospectus. The Company reserves the right, in its sole discretion, to accept or reject any subscription, in whole or in part, subject to applicable law and the terms of the Offering. Any subscription funds attributable to a rejected subscription or rejected portion thereof shall be returned to the Subscriber promptly, without interest or deduction.

2.             MINIMUM OFFERING; ESCROW; CLOSINGS.

All subscription funds received from investors will be deposited in a non-interest-bearing escrow account maintained with the escrow agent identified in the Prospectus (the “Escrow Agent”). No initial closing will occur, and no funds will be released to the Company, unless subscriptions for at least 800,000 Shares ($4,000,000) have been accepted and the corresponding funds deposited in escrow on or before January 31, 2027 (the “Termination Date”). Upon satisfaction of this minimum offering condition, the Company may conduct an initial closing and one or more subsequent closings, for up to a maximum of 1,400,000 Shares ($7,000,000), in accordance with the Prospectus. Funds will be disbursed pursuant to joint instructions from the Company and the Placement Agents in accordance with the escrow agreement. If the minimum offering condition is not satisfied by the Termination Date, the Offering will terminate and all subscription funds will be returned promptly to subscribers without interest or deduction. Shares will be issued in book-entry form upon completion of the applicable closing.

3.             ACCOUNT TYPE. Check only one box.

¨ Individual Ownership (One signature required below) ¨ Trust
¨ Joint Tenants with Rights of Survivorship (All tenants must sign below) ¨ Corporation
¨ IRA
¨ Tenants in Common (All tenants must sign below) ¨ Limited Partnership
¨ Other (Please specify): ________________________ ¨ Limited Liability Company
¨ General Partnership

4.             INVESTOR INFORMATION

Subscriber / Trustee Name: _______________________________________________________________________________________

Social Security or Taxpayer Identification Number: _____________________________________________________________________

Street Address: ________________________________________________________________________________________________

City: ________________________________________________________________________________________________________

State: _______________________________________________________________________________________________________

ZIP: ________________________________________________________________________________________________________

Daytime Phone: _______________________________________________________________________________________________

Email: _______________________________________________________________________________________________________

Date of Birth: _________________________________________________________________________________________________

Country of Citizenship: __________________________________________________________________________________________

To be completed by Trusts, Corporations and Partnerships

Entity Name / Title of Trust: ______________________________________________________________________________________

Tax Id: ______________________________________________________________________________________________________

Date of Trust: _________________________________________________________________________________________________

Jurisdiction of Entity: ___________________________________________________________________________________________

Formation Date of Entity: ________________________________________________________________________________________

5.             SUBSCRIBER REPRESENTATIONS AND ACKNOWLEDGMENTS. The undersigned hereby confirms this agreement to purchase shares on the terms and conditions set forth herein and acknowledges and represents each of the following:

a. I have received, read and understand the Registration Statement, including the related Prospectus, wherein the terms, conditions and risks of the Offering are described, and agree to be bound by the terms and conditions. I understand that an investment in the Shares involves substantial risks, including the possible loss of the entire investment.
b. I have the authority and capacity to enter into this agreement and make the investment contemplated hereby.
c. I acknowledge and agree that my investment will be deemed to be accepted by the Company only when it is signed by a duly authorized officer of the Company.
d. Neither I nor, to my knowledge, any person for whose benefit I am acquiring the Shares is a person or entity subject to sanctions administered by the U.S. Department of the Treasury’s Office of Foreign Assets Control or otherwise prohibited under applicable law from purchasing the Shares. The undersigned agrees to provide such additional information as the Company, the Placement Agents, the Escrow Agent or their respective agents may reasonably request to comply with applicable anti-money laundering, sanctions and investor identification requirements.

SIGNATURES

Owner Signature Co-Owner Signature
Date: Date:

Signature of Custodians or Trustee as applicable:

Authorized Signature – Custodian or Trustee

Date: __________________________________________________

ACCEPTED this __ day of _____, 202_:

Encore Medical, Inc.

By:

[Name and title]

SUBMISSION AND PAYMENT INSTRUCTIONS

Mail Documents with check or email documents to [escrow agent].

Name

Attention:

Address:

Email:

Checks – Make payable to:

Acquiom Clearinghouse LLC, as Escrow Agent for Encore Medical, Inc.

Wire Instructions:

Bank

ABA No.

Acct No.

Acct Name:

Reference: Encore Medical, Inc.

WE HAVE THE RIGHT, AT OUR SOLE DISCRETION, TO ACCEPT OR REJECT THIS SUBSCRIPTION, IN WHOLE OR IN PART. THIS SUBSCRIPTION AGREEMENT AND ALL RIGHTS HEREUNDER SHALL BE GOVERNED BY AND INTERPRETED IN ACCORDANCE WITH THE LAWS OF THE STATE ON MINNESOTA WITHOUT GIVING EFFECT TO THE PRINCIPLES OF CONFLICT LAWS.

Back to all agreements